Glucose Infusion Rate (GIR) Calculator

Glucose Infusion Rate (GIR) Calculator for Endocrinology. Roughly 4-6 mg/kg/min matches basal glucose turnover in a term neonate; preterm and small-for-gestational-age infants may need slightly more. A stable requirement of 8-10 mg/kg/min or higher to maintain normoglycemia is the classic biochemical fingerprint of hyperinsulinism (the PES considers this a supportive diagnostic criterion), whereas very low tolerated GIR suggests a glycogen-storage or gluconeogenic defect once dextrose is weaned. Delivery approaching 12-14 mg/kg/min represents the ceiling of glucose oxidation; pushing higher rarely helps and drives fat deposition and hyperglycemia. Rising GIR demand over hours signals an evolving problem, not just a number to chase.

How this calculator works

GIR expresses the rate of intravenous dextrose delivery normalized to body weight, in milligrams of glucose per kilogram per minute (mg/kg/min). It is computed as GIR = (dextrose concentration in % × infusion rate in mL/hr) / (6 × weight in kg), where the constant 6 converts a g/dL concentration and mL/hr flow into mg/kg/min. Equivalently, since a 1% dextrose solution contains 10 mg/mL, GIR = (fluid rate mL/kg/day × dextrose %) × 0.007. When several dextrose-containing fluids run simultaneously (maintenance fluids, TPN, medication carriers, dextrose boluses), each line's contribution must be summed to obtain the total GIR.

When to use this calculator

Use it at the bedside whenever a neonate or child is receiving IV dextrose: to prescribe a starting rate (typically 4-8 mg/kg/min in a term newborn, approximating normal endogenous hepatic glucose production), to titrate up in stepwise increments for persistent hypoglycemia, and above all to quantify the demand needed to maintain euglycemia. A GIR requirement exceeding 8-10 mg/kg/min to keep glucose normal is a hallmark of hyperinsulinism and should trigger endocrine workup. It also guards against exceeding the ~12-14 mg/kg/min maximal oxidative capacity, above which lipogenesis, hepatic steatosis, and CO2 overproduction occur. It is not a diagnostic test by itself and does not apply to enteral or oral carbohydrate intake.

Inputs used

  • Dextrose concentration
  • Infusion rate
  • Weight

Clinical interpretation

Roughly 4-6 mg/kg/min matches basal glucose turnover in a term neonate; preterm and small-for-gestational-age infants may need slightly more. A stable requirement of 8-10 mg/kg/min or higher to maintain normoglycemia is the classic biochemical fingerprint of hyperinsulinism (the PES considers this a supportive diagnostic criterion), whereas very low tolerated GIR suggests a glycogen-storage or gluconeogenic defect once dextrose is weaned. Delivery approaching 12-14 mg/kg/min represents the ceiling of glucose oxidation; pushing higher rarely helps and drives fat deposition and hyperglycemia. Rising GIR demand over hours signals an evolving problem, not just a number to chase.

Worked example

A 3 kg term newborn receives D12.5% at 10 mL/hr through a central line. GIR = (12.5 × 10) / (6 × 3) = 125 / 18 = 6.9 mg/kg/min. This sits in the physiologic range and is a reasonable starting point. If glucose remains low despite escalation to a GIR above 10 mg/kg/min, the infant's inability to maintain euglycemia on supra-physiologic glucose delivery strongly suggests congenital hyperinsulinism, and a critical sample plus glucagon-response test should be obtained.

Limitations and safety notes

The formula is only as accurate as its inputs: unrecognized dextrose from drug carriers, flushes, or a second infusion line will make the calculated GIR falsely low, and using stated versus actually-infused rates (pump under-delivery, line interruptions) introduces error. It says nothing about whether that GIR is achieving euglycemia; it must always be paired with bedside glucose values. Peripheral lines cannot safely carry the high dextrose concentrations (>D12.5%) that a high GIR may require, so a central line becomes the limiting factor. It also does not account for concurrent insulin, glucagon, or enteral feeds, and is not designed for children on established oral diets.

Frequently asked questions

Where does the constant 6 in the formula come from?

It reconciles units. Dextrose % is g per 100 mL and the rate is mL/hr, so their product is g/hr per 100 mL; converting grams to milligrams (×1000), hours to minutes (÷60), and dividing by weight collapses to dividing by 6 to yield mg/kg/min.

What GIR should I start a hypoglycemic term newborn on?

About 4-8 mg/kg/min, which approximates normal endogenous hepatic glucose production. This is commonly achieved with D10W at roughly 60-100 mL/kg/day, then titrated to the glucose response.

Why does a high GIR requirement point to hyperinsulinism?

Insulin both suppresses endogenous glucose output and drives peripheral uptake, so an affected infant needs supra-physiologic exogenous glucose to stay euglycemic. Needing more than 8-10 mg/kg/min is a well-recognized supportive criterion in the Pediatric Endocrine Society framework.

Is there an upper limit to GIR?

Practically yes. Glucose oxidation saturates around 12-14 mg/kg/min; beyond that, excess glucose is converted to fat, causing hepatic steatosis, hyperglycemia, and increased CO2 production, so escalating further is usually counterproductive and other therapies (e.g. diazoxide, glucagon) should be considered.

Do I need to include every dextrose source?

Yes. Sum the GIR contribution of maintenance fluids, TPN, dextrose-containing medication infusions, and any boluses; omitting a line understates the true glucose load and can mask a hyperinsulinism-level requirement.

References

  • Thornton PS, Stanley CA, De Leon DD, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr. 2015;167(2):238-45. PMID: 25957977.
  • Committee on Fetus and Newborn, Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011;127(3):575-9. PMID: 21357346.

Editorial review and citation methodology

Reviewed by the Quick Medical Calculator Editorial Team. Last reviewed: May 31, 2026. The review checks calculator inputs, intended population, interpretation, limitations, and source alignment.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators